Regulus Therapeutics Inc. (RGLS)
NASDAQ: RGLS · Real-Time Price · USD
1.960
+0.210 (12.00%)
At close: Apr 2, 2025, 4:00 PM
1.820
-0.140 (-7.14%)
After-hours: Apr 2, 2025, 7:46 PM EDT

Regulus Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
13010326234690
Upgrade
Market Cap Growth
299.81%299.81%12.20%-49.82%-49.09%384.92%
Upgrade
Enterprise Value
5517-1-151987
Upgrade
Last Close Price
1.961.581.281.373.1513.50
Upgrade
PS Ratio
----9.03
Upgrade
PB Ratio
1.681.351.220.690.843.47
Upgrade
P/TBV Ratio
1.361.361.220.690.843.49
Upgrade
EV/Sales Ratio
----8.67
Upgrade
Debt / Equity Ratio
0.010.010.150.210.140.20
Upgrade
Asset Turnover
-----0.25
Upgrade
Inventory Turnover
10.8810.887.036.125.634.24
Upgrade
Quick Ratio
10.1110.112.793.3611.552.73
Upgrade
Current Ratio
10.9810.983.313.7812.483.17
Upgrade
Return on Equity (ROE)
-95.00%-95.00%-110.27%-64.19%-68.67%-68.33%
Upgrade
Return on Assets (ROA)
-54.42%-54.42%-50.20%-30.65%-32.78%-22.20%
Upgrade
Return on Capital (ROIC)
-61.47%-61.47%-60.28%-34.32%-37.07%-26.45%
Upgrade
Earnings Yield
-35.70%-44.80%-116.04%-122.76%-60.48%-17.42%
Upgrade
FCF Yield
-32.36%-40.60%-105.78%-112.20%-53.02%-13.88%
Upgrade
Buyback Yield / Dilution
-197.18%-197.18%-24.25%-78.07%-145.01%-102.65%
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q